Provided by Tiger Trade Technology Pte. Ltd.

Humacyte, Inc.

0.4723
-0.0057-1.19%
Post-market: 0.47640.0041+0.87%19:53 EDT
Volume:3.91M
Turnover:1.83M
Market Cap:131.30M
PE:-0.95
High:0.4799
Open:0.4792
Low:0.4600
Close:0.4780
52wk High:1.97
52wk Low:0.4600
Shares:278.00M
Float Shares:245.00M
Volume Ratio:0.79
T/O Rate:1.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4975
EPS(LYR):-0.2582
ROE:-547.87%
ROA:-49.87%
PB:4.20
PE(LYR):-1.83

Loading ...

Humacyte Is Maintained at Buy by BTIG

Dow Jones
·
May 14

Humacyte Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

Humacyte Q1 EPS $(0.09) Beats $(0.11) Estimate, Sales $495.000K Miss $1.455M Estimate

Benzinga Earnings
·
May 13

Humacyte Announces First Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
May 13

Humacyte appoints Todd Rasmussen chief surgical officer

Reuters
·
May 12

Humacyte Appoints DR. Todd E. Rasmussen as Chief Surgical Officer

THOMSON REUTERS
·
May 12

Press Release: Humacyte Appoints Dr. Todd E. Rasmussen as Chief Surgical Officer

Dow Jones
·
May 12

Humacyte Inc expected to post a loss of 12 cents a share - Earnings Preview

Reuters
·
May 11

Humacyte risks Nasdaq delisting after shares trade below $1 bid price minimum

Reuters
·
May 09

Humacyte Inc expected to post a loss of 12 cents a share - Earnings Preview

Reuters
·
May 08

Humacyte sets first-quarter results webcast and conference call

Reuters
·
May 08

Humacyte to Announce 2026 First Quarter Financial Results and Provide Business Update on May 13, 2026

THOMSON REUTERS
·
May 08

Humacyte (HUMA) Motion to Dismiss Ruling Keeps Key Securities Claims Alive

TIPRANKS
·
May 05

Humacyte (HUMA) Gets a Buy from Barclays

TIPRANKS
·
Apr 29

Humacyte Price Target Maintained With a $3.00/Share by BTIG

Dow Jones
·
Apr 28

Humacyte hosts virtual KOL event on ATEV for dialysis AV access

Reuters
·
Apr 27

Humacyte Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Apr 24

Humacyte Inc - Enters Third Amendment to Distribution Agreement With Fresenius on April 21, 2026 - SEC Filing

THOMSON REUTERS
·
Apr 24

Humacyte Inc - Gains Sole Worldwide Rights to Distribution Product - SEC Filing

THOMSON REUTERS
·
Apr 24

Humacyte Inc - to Pay Fresenius Mid-Single to Low Double Digit Royalties on U.S. Sales - SEC Filing

THOMSON REUTERS
·
Apr 24